Sangamo shares collapse.

Sangamo shares fell sharply today by 27%.

This decline comes as a result of the termination of the cooperation agreement with the American company Pfizer.

This is scheduled to start implementing the termination on April 21, 2025.

This comes as a result of Pfizer's decision not to continue submitting requests for biological products

and not to continue submitting the marketing license for the drug Gyroctocogene Vetylparvovic.